Standard Biotools Correlations
LAB Stock | USD 1.23 0.02 1.60% |
The current 90-days correlation between Standard Biotools and FACT II Acquisition is -0.02 (i.e., Good diversification). The correlation of Standard Biotools is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Standard Biotools Correlation With Market
Weak diversification
The correlation between Standard Biotools and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Standard Biotools and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Standard Stock
0.75 | NKTR | Nektar Therapeutics | PairCorr |
0.61 | MRK | Merck Company | PairCorr |
0.61 | KMDA | Kamada | PairCorr |
0.61 | INTC | Intel Earnings Call This Week | PairCorr |
Moving against Standard Stock
0.59 | TRV | The Travelers Companies | PairCorr |
0.49 | MCD | McDonalds | PairCorr |
0.36 | VZ | Verizon Communications Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Standard Stock performing well and Standard Biotools Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Standard Biotools' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
STRR | 3.07 | 0.02 | (0.01) | 0.17 | 3.94 | 7.22 | 38.42 | |||
VNRX | 4.58 | 0.76 | 0.10 | (1.10) | 4.46 | 12.50 | 47.78 | |||
BDSX | 6.09 | (0.46) | 0.00 | (4.08) | 0.00 | 13.79 | 58.86 | |||
SER | 3.23 | 0.01 | (0.01) | 0.14 | 4.88 | 7.95 | 25.02 | |||
JEF | 1.69 | 0.18 | 0.15 | 0.24 | 1.51 | 4.23 | 12.07 | |||
RJF | 0.99 | 0.12 | 0.10 | 0.24 | 1.05 | 2.33 | 6.99 | |||
FACT | 1.34 | (0.08) | 0.00 | 0.40 | 0.00 | 3.33 | 20.16 |
Standard Biotools Corporate Management
Jeffrey Black | Chief Officer | Profile | |
Shane Bowen | Chief Officer | Profile | |
Elizabeth Jensen | Chief Officer | Profile | |
Mark Spearman | Sr Communications | Profile | |
Mike Musgnug | Senior Officer | Profile | |
John Graziano | Vice Relations | Profile |